← All candidates
17 insider buys in the last year — $221.48M in all.
82 filings on record.
SGPSpyGlass Pharma, Inc.
—
$28.96
+1.05% · Sep 15
17 insider buys in the last year — $221.48M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 17 buys◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 2 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Ra Capital Management, L.p.
Bought $55.07M on Feb 9 — 3,441,966 sh @ $16.00, held indirect, 58% of their stake.
4 of 8 positions beat the S&P
10% owner
Yang Rick
Bought $15.00M on Feb 9 — 937,500 sh @ $16.00, held indirect, 16% of their stake.
0 of 1 position beat the S&P
10% owner
Walker Paul Edward
Bought $15.00M on Feb 9 — 937,500 sh @ $16.00, held indirect, 16% of their stake.
0 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
77 more transactions on Pro →Context
Wall St
$45.00 avg target
+55.4% vs today · 5 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 1 quarters beat
Q1 '26−$0.69 act−$0.33
The file stays open
82 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice